| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-hydroxylase/17, 20-lyase (CYP17) Deficient Mice

From the * Department of Biochemistry &
Molecular and Cellular Biology, Georgetown University Medical Center,
Washington, DC; and the
Department of
Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School
of Public Health, Baltimore, Maryland.
| Correspondence to: Dr Vassilios Papadopoulos, Georgetown University Medical Center, Department of Biochemistry & Molecular and Cellular Biology, 3900 Reservoir Road NW, Washington DC, 20057 (e-mail: papadopv{at}georgetown.edu). |
| Received for publication October 24, 2006; accepted for publication January 17, 2007. |
| Abstract |
|---|
|
|
|---|
-hydroxylase/17, 20-lyase (CYP17) is crucial for
cortisol and sex steroid biosynthesis. In a previous study we examined CYP17
function by generating mice with a targeted CYP17 deletion. We found
that in addition to its role in steroid biosynthesis, CYP17 is present in germ
cells. In the present study we examined the effect of CYP17 on sperm
morphology. Disorganization of the sperm midpiece, small sperm mitochondria
with reduced inner membranes and matrix, and irregular sperm shape were found
to be associated with the CYP17 gene deletion. Treating the mice
carrying the CYP17 deletion with testosterone did not alleviate the
observed sperm phenotypes, suggesting that CYP17 acts in a
testosterone-independent manner. These results suggest that CYP17, in addition
to its role in androgen formation, is critical for proper mitochondrial
architecture and sperm morphology and thus for sperm function and normal
fertility.
Key words: Gene deletion, steroidogenesis, mitochondria architecture, fertility
-hydroxylase/17, 20-lyase (CYP17; EC 1.14.99.9) is
a bifunctional microsomal monooxygenase that mediates the
17
-hydroxylation of pregnenolone or progesterone to yield 17
-OH
pregnenolone or 17
-OH progesterone, respectively. Cleavage of the C17,
20 bond leads to cortisol and sex steroid biosynthesis
(Hall, 1986;
Mellon and Griffin, 2002;
Miller, 2002). Human CYP17
deficiency results in impaired cortisol, androgen, and estrogen production, as
well as mineralocorticoid overproduction, which potentially leads to
hypertension, pseudohermaphroditism, and delay in sexual maturation
(Kater and Biglieri, 1994;
Yanase, 1995; Rainey et al,
2002). CYP17 is also a potent oxidant with catalytic properties distinct from
its 17
-hydroxylase/17, 20-lyase activity
(Lieberman and Warne, 2001).
Our in vitro studies demonstrated that CYP17 has squalene monooxygenase
(epoxidase) activity, critical for cholesterol biosynthesis
(Liu et al, 2005b). Recently we investigated the function of CYP17 in vivo by generating mice with a targeted deletion of CYP17. An 80% reduction in intratesticular and circulating testosterone levels occurred in chimeric mice carrying the CYP17 deletion (Liu et al, 2005a). Interestingly, the testosterone that remained was sufficient to support spermatogenesis. However, the male chimeras consistently failed to generate heterozygous CYP17 mice. Unexpectedly, CYP17 was found to be present in germ cells. Moreover, more than 50% of the chimeric mice sperm were morphologically abnormal, and many had impaired motility (Liu et al, 2005a).
The objective of the present study was to further determine the effect of the CYP17 deletion on sperm morphology and fertility. Using hormone replacement, we also addressed the question of whether changes in the sperm might be the consequence of reduced intratesticular androgen. We show that CYP17 is necessary for the structure and organization of the sperm mitochondria and that the mitochondrial defects observed in CYP17 chimeric mice were not alleviated by androgen treatment.
| Materials and Methods |
|---|
|
|
|---|
|
Leydig Cell Morphology![]()
For ultrastructural analyses, mice were perfused through the heart with 5%
glutaraldehyde in 0.1 M sodium cacodylate buffer. After initial fixation,
testis blocks were immersed in 5% glutaraldehyde overnight, postfixed in
cacodylate-buffered 1% osmium tetroxide, washed, dehydrated, and embedded in
Epon 812. Semithin sections (1 µm) were mounted on glass slides and stained
with toluidine blue. Brightfield images were captured with a Nikon Eclipse 800
microscope system equipped with a Princeton Instruments CCD camera (Trenton,
NJ) and digitized with IPLab software.
Sperm Morphology and Ultrastructure![]()
For light microscopy analysis of epididymal spermatozoa, epididymes from
wild-type (n = 4) and chimeric (n = 5) mice carrying the CYP17 gene
deletion were dissected. Sperm from cauda epididymes were extruded into
phosphate-buffered saline and observed under phase-contrast microscopy.
|
|
| Results |
|---|
|
|
|---|
Electron microscopy (EM) was used to examine sperm ultrastructure in wild-type and chimeric mouse sperm. The most apparent differences were seen in the sperm midpiece. Figures 3 and 4 show representative EM longitudinal sections of spermatozoa from wild-type animals (Figures 3A through F and 4A through C), displaying normal mitochondrial sheathes in the middle piece and unaffected annuli (ring-like structures) at the junction of the middle and principal pieces. No differences were seen in the sperm annuli between chimeric and wild-type mice (Figures 3G through M and 4D through G), and no differences were seen in the principal pieces. However, differences were seen in the middle pieces. In sperm from chimeric mice, the middle pieces were irregularly shaped, small, and disorganized. Cross-sections of chimeric CYP17 and wild-type sperm usually showed abnormal mitochondrial shape and organization in the middle pieces of chimeric mouse sperm (Figure 5D through G). These results were consistent with our earlier report that the majority of sperm of chimeric mice appeared morphologically abnormal by light microscopy and that many had impaired motility (Liu et al, 2005a). No other differences were seen even at high magnification (40 000x60 000x).
|
|
To examine the possibility that CYP17-induced sperm morphology changes were due to decreased androgen levels, newborn chimeric male pups were treated with testosterone for 2 months. Testosterone treatment did not rescue the sperm defects (Figure 6) or alter fertility status (data not shown). These observations suggest that CYP17 may affect sperm development directly rather than exerting its effects indirectly through reduced androgen levels.
|
| Discussion |
|---|
|
|
|---|
Sperm morphology has been shown to correlate with sperm function in fertilization and thus to have prognostic value in assisted reproduction. For example, abnormal mitochondrial architecture in mature sperm has been correlated with loss of motility and fertilization potential (Chemes and Raue, 2003). During spermatogenesis mitochondria undergo a dramatic reorganization in the middle piece of the sperm tail that results in a helical alignment of similarly shaped and sized organelles along the sperm axoneme, referred to as the mitochondrial sheath (Kissel et al, 2005). Sperm dysfunction has been associated with the absence of mitochondria around the axoneme, with the middle piece appearing thin and bent and with an abnormal fibrous sheath extending up to the neck region, thus preventing mitochondrial assembly around the axoneme (Zamboni, 1992). Ultrastructural analyses of abnormally shaped spermatozoa often show structural irregularities in the mitochondrial sheath (Olson et al, 2004). Infertile human males also are reported to exhibit ultrastructural defects in the mitochondria of their middle pieces (Foresta et al, 2002).
Such previous studies provided the rationale for our analysis of sperm ultrastructure in the CYP17 knockout mice. Our intent was to understand how CYP17 affects sperm morphology and motility. To this end, EM was used to analyze spermatozoa obtained from CYP17 chimeric and wild-type mice. The CYP17 deletion was found to have a profound effect on mitochondrial architecture. In particular, structural irregularities and mitochondrial sheath disorganization in the midpiece were seen in sperm from the chimeric in comparison with the wild-type mice. In particular, the mitochondria of sperm from the chimeric mice were small, abnormally shaped, and disorganized. Testosterone supplementation from birth to adulthood did not rescue abnormal sperm morphology, suggesting that in addition to its critical role in androgen formation, CYP17 is necessary for proper sperm development and function. These results suggest that the effects of the CYP17 deletion may be direct rather than through reduced amounts of androgen.
Kissel et al (2005) recently reported abnormalities in the morphology of sperm from Sept4 gene knockout mice, including alteration of mitochondrial architecture and annulus formation, as well as effects on the removal of residual cytoplasm during sperm maturation. Although the CYP17 deletion also resulted in altered sperm mitochondrial architecture, there were no apparent annulus or cytoplasm abnormalities.
In previous studies we reported that CYP17, in addition to its
17
-hydroxylase/17,20-lyase activity, has squalene monooxygenase
(epoxidase) activity that is critical for cholesterol biosynthesis
(Liu et al, 2005b). MA-10
Leydig cells have very low amounts of CYP17. Nonetheless, we observed that
MA-10 Leydig cells in which CYP17 was knocked out had reduced ATP
levels compared with control MA-10 cells (data not shown), suggesting that
CYP17 may play a role in mitochondrial function in these cells. Taken together
with the results presented herein, these findings suggest that the squalene
monooxygenase (epoxidase) activity of CYP17 may affect mitochondrial function,
leading to altered sperm morphology and infertility.
In conclusion, the data presented here provide evidence that CYP17 plays a critical role in the organization and structure of the sperm mitochondria. These mitochondrial defects, rather than an altered androgen environment, likely cause the defects in sperm motility and altered fertilization potential in mice with a targeted CYP17 deletion.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Chemes HE, Rawe VY. Sperm pathology: a step beyond descriptive
morphology. Origin, characterization and fertility potential of abnormal sperm
phenotypes in infertile men. Hum Reprod Update. 2003; 9: 405
-428.
Foresta C, Flohe L, Garolla A, Roveri A, Ursini F, Maiorino M. Male
fertility is linked to the selenoprotein phospholipids hydroperoxide
glutathione peroxidase. Biol Reprod. 2002; 67: 967
-971.
Hall PF. Cytochromes P450 and regulation of steroid synthesis. Steroids. 1986;48: 131 -196.[CrossRef][Medline]
James PI, Nyby JC. Testosterone rapidly affects the expression of copulatory behavior in house mice. Physiol Behav. 2002; 75: 287 -294.[CrossRef][Medline]
Kater CE, Biglieri FG. Disorders of steroid 17-hydroxylase deficiency. Endocrinol Metab Clin North Am. 1994; 23: 341 -357.[Medline]
Kissel H, Georgescu M, Larisch S, Manova K, Hunnicutt G, Steller H. The Sept4 septin locus is required for sperm terminal differentiation in mice. Dev Cell. 2005;8: 353 -384.[CrossRef][Medline]
Lieberman S, Warne PA. 17-Hydroxylase: an evaluation of the present view of its catalytic role in steroidogenesis. J Steroid Biochem Mol Biol. 2001;78: 299 -312.[CrossRef][Medline]
Liu Y, Yao Z, Bendavid C, Borgmeyer C, Han Z, Cavalli LR, Chan W,
Folmer J. Zirkin BR, Haddad BR, Gallicano GI, Papadopoulos V.
Haploinsufficiency of cytochrome P450 17
-hydroxylase/17,20 lyase
(CYP17) causes infertility in male mice. Mol
Endocrinol. 2005a;19: 2380
-2389.
Liu Y, Yao Z, Papadopoulos V. Cytochrome P450 17
hydroxylase/17,20 lyase (CYP17) function in cholesterol biosynthesis:
identification of squalene monooxygenase (epoxidase) activity associated with
CYP17 in Leydig cells. Mol Endocrinol. 2005b; 19: 1918
-1931.
Martinez-Sanchis S, Aragon CM, Salvador A. Cocaine-induced locomotor activity is enhanced by exogenous testosterone. Physiol Behav. 2002;76: 605 -609.[CrossRef][Medline]
Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab. 2002; 13: 35 -43.[CrossRef][Medline]
Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol. 2002; 198: 7 -14.[CrossRef][Medline]
New MI. Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol. 2003;211: 75 -83.[CrossRef][Medline]
Okano T, Murase T, Tsubota T. Spermatogenesis, serum testosterone levels and immunolocalization of steroidogenic enzymes in the wild male Japanese black bear (Ursus thibetanus japonicus). J Vet Med Sci. 2003;65: 1093 -1099.[CrossRef][Medline]
Olson GE, Winfrey VP, Hill KE, Burk RF. Sequential development of
flagella defects in spermatids and epididymal spermatozoa of
selenium-deficient rats. Reproduction. 2004; 127: 335
-342.
Thuillier R, Wang Y, Culty M. Prenatal exposure to estrogenic
compounds alters the expression pattern of platelet-derived growth factor
receptors and in neonatal rat testis: identification of gonocytes as targets
of estrogen exposure. Biol Reprod. 2003; 68: 867
-880.
Yanase T. 17
-hydroxylase/17,20 lyase defects. J
Steroid Biochem Mol Biol. 1995; 53: 153
-157.[CrossRef][Medline]
Zhang FP, Pakarainen T, Poutanen M, Toppari J, Huhtaniemi I. The
low gonadotropin-independent constitutive production of testicular
testosterone is sufficient to maintain spermatogenesis. Proc Natl
Acad Sci USA. 2003;100: 13692
-13697.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |